Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer
In this study, we investigated the cost-effectiveness of these two modalities in the treatment of intermediate-high risk prostate cancer.
Source: Brachytherapy - Category: Cancer & Oncology Authors: Charles C. Vu, Kevin G. Blas, Thomas B. Lanni, Gary S. Gustafson, Daniel J. Krauss Source Type: research